REBECCA WHITE: Open Payments
NPI 1629358056 · CALHOUN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,284 in 76 payments from 20 companies in 2025. Trend: 2023 $1,290 · 2024 $1,422 · 2025 $1,284
Food & beverage: $1,144Travel & lodging: $140
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $272 |
| Axsome Therapeutics, Inc. | 13 | $193 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $175 |
| Vanda Pharmaceuticals Inc. | 4 | $99 |
| Janssen Pharmaceuticals, Inc | 3 | $77 |
| Teva Pharmaceuticals USA, Inc. | 3 | $70 |
| Noven Therapeutics, LLC | 3 | $57 |
| Collegium Pharmaceutical, Inc. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
Products named: VRAYLAR, Auvelity, FANAPT, SPRAVATO, AUSTEDO XR, Xelstrym, Jornay PM, CAPLYTA.
Industry payments across GA — which companies pay providers there.
